# The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

> **NCT03810495** · PHASE1 · COMPLETED · sponsor: **Go Medical Industries Pty Ltd** · enrollment: 20 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** naltrexone implant

## Key facts

- **NCT ID:** NCT03810495
- **Lead sponsor:** Go Medical Industries Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-11
- **Primary completion:** 2021-03-18
- **Final completion:** 2021-03-22
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810495, "The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03810495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*